Trademark: MYR PHARMACEUTICALS 2178572
Word
MYR PHARMACEUTICALS
Device Descrption:
PRISM WITH LTRS
ID
2178572
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
26 October 2020
Registration Date
26 October 2020
Renewal Date
26 October 2030
Owner(s)
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 1:
Chemicals for use in industry and science; peptides substrates for scientific and industrial purposes; oligopeptides; polypeptides; proteins [raw material]; polynucleotides [chemicals for scientific purposes]; oligonucleotides [chemicals for scientific purposes]; nucleic acids; SiRNA molecules; small molecules having a molar mass of 160 to 480 [for scientific purposes].
Chemicals for use in industry and science; peptides substrates for scientific and industrial purposes; oligopeptides; polypeptides; proteins [raw material]; polynucleotides [chemicals for scientific purposes]; oligonucleotides [chemicals for scientific purposes]; nucleic acids; SiRNA molecules; small molecules having a molar mass of 160 to 480 [for scientific purposes].
Class 5:
Pharmaceutical and veterinary preparations; biological preparations for medical purposes; biological preparations for veterinary purposes; biochemical preparations for medical purposes; biochemical preparations for veterinary purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; medicines for medical purposes; medicines for veterinary purposes; pharmaceutical preparations for treating liver diseases and disorders; pharmaceutical products for hepatitis B; pharmaceutical products for hepatitis D; pharmaceutical preparations for dyslipidemia; pharmaceutical preparations for nonalcoholic steatohepatitis [NASH]; pharmaceutical preparations for primary biliary cholangitis [PBC]; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP].
Pharmaceutical and veterinary preparations; biological preparations for medical purposes; biological preparations for veterinary purposes; biochemical preparations for medical purposes; biochemical preparations for veterinary purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; medicines for medical purposes; medicines for veterinary purposes; pharmaceutical preparations for treating liver diseases and disorders; pharmaceutical products for hepatitis B; pharmaceutical products for hepatitis D; pharmaceutical preparations for dyslipidemia; pharmaceutical preparations for nonalcoholic steatohepatitis [NASH]; pharmaceutical preparations for primary biliary cholangitis [PBC]; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP].
Class 9:
Scientific, surveying, weighing, measuring apparatus and instruments; apparatus and instruments for scientific research, in particular scientific research in laboratories; data processing apparatus; computers; CDs; DVDs; digital recording media; computer software.
Scientific, surveying, weighing, measuring apparatus and instruments; apparatus and instruments for scientific research, in particular scientific research in laboratories; data processing apparatus; computers; CDs; DVDs; digital recording media; computer software.
Class 42:
Scientific and technological services and research and design relating thereto; industrial analysis services; industrial research services; scientific research for medical, chemical, biological, veterinary and pharmaceutical purposes; scientific and technological services and research and design related thereto in the field of hepatitis B; scientific and technological services and research and design related thereto in the field of hepatitis D; scientific and technological services and research and design related thereto in the field of dyslipidemia; scientific and technological services and research and design related thereto in the field of nonalcoholic steatohepatitis [NASH]; scientific and technological services and research and design related thereto in the field of primary biliary cholangitis [PBC]; scientific and technological services and research and design related thereto in the field of inflammatory diseases; scientific and technological services and research and design related thereto in the field of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services and research and design related thereto in the field of metabolic diseases; scientific and technological services and research and design related thereto in the field of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; design and development of computer hardware and software; scientific and technological services in the field of preclinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], primary biliary cholangitis [PBC], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services in the field of clinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], primary biliary cholangitis [PBC], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [MVP].
Scientific and technological services and research and design relating thereto; industrial analysis services; industrial research services; scientific research for medical, chemical, biological, veterinary and pharmaceutical purposes; scientific and technological services and research and design related thereto in the field of hepatitis B; scientific and technological services and research and design related thereto in the field of hepatitis D; scientific and technological services and research and design related thereto in the field of dyslipidemia; scientific and technological services and research and design related thereto in the field of nonalcoholic steatohepatitis [NASH]; scientific and technological services and research and design related thereto in the field of primary biliary cholangitis [PBC]; scientific and technological services and research and design related thereto in the field of inflammatory diseases; scientific and technological services and research and design related thereto in the field of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services and research and design related thereto in the field of metabolic diseases; scientific and technological services and research and design related thereto in the field of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; design and development of computer hardware and software; scientific and technological services in the field of preclinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], primary biliary cholangitis [PBC], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services in the field of clinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], primary biliary cholangitis [PBC], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [MVP].
Class 44:
Medical services; veterinary services; medical and veterinary services, in particular medical analysis in connection with the treatment of individuals; providing information in the medical field, veterinary field and pharmacology; services of health centres; services of clinics (ambulances); therapy services; hygienic and beauty care for human beings and animals.
Medical services; veterinary services; medical and veterinary services, in particular medical analysis in connection with the treatment of individuals; providing information in the medical field, veterinary field and pharmacology; services of health centres; services of clinics (ambulances); therapy services; hygienic and beauty care for human beings and animals.